Morkunas Bernardas, Gal Balint, Galloway Warren R J D, Hodgkinson James T, Ibbeson Brett M, Tan Yaw Sing, Welch Martin, Spring David R
Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, UK.
Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, UK.
Beilstein J Org Chem. 2016 Jul 11;12:1428-33. doi: 10.3762/bjoc.12.137. eCollection 2016.
Pyocyanin is a small molecule produced by Pseudomonas aeruginosa that plays a crucial role in the pathogenesis of infections by this notorious opportunistic pathogen. The inhibition of pyocyanin production has been identified as an attractive antivirulence strategy for the treatment of P. aeruginosa infections. Herein, we report the discovery of an inhibitor of pyocyanin production in cultures of wild-type P. aeruginosa which is based around a 4-alkylquinolin-2(1H)-one scaffold. To the best of our knowledge, this is the first reported example of pyocyanin inhibition by a compound based around this molecular framework. The compound may therefore be representative of a new structural sub-class of pyocyanin inhibitors, which could potentially be exploited in in a therapeutic context for the development of critically needed new antipseudomonal agents. In this context, the use of wild-type cells in this study is notable, since the data obtained are of direct relevance to native situations. The compound could also be of value in better elucidating the role of pyocyanin in P. aeruginosa infections. Evidence suggests that the active compound reduces the level of pyocyanin production by inhibiting the cell-cell signalling mechanism known as quorum sensing. This could have interesting implications; quorum sensing regulates a range of additional elements associated with the pathogenicity of P. aeruginosa and there is a wide range of other potential applications where the inhibition of quorum sensing is desirable.
绿脓菌素是由铜绿假单胞菌产生的一种小分子,在这种臭名昭著的机会致病菌的感染发病机制中起着关键作用。抑制绿脓菌素的产生已被确定为一种有吸引力的抗毒力策略,用于治疗铜绿假单胞菌感染。在此,我们报告了在野生型铜绿假单胞菌培养物中发现一种绿脓菌素产生抑制剂,该抑制剂基于4-烷基喹啉-2(1H)-酮支架。据我们所知,这是首次报道基于该分子框架的化合物对绿脓菌素的抑制作用。因此,该化合物可能代表了绿脓菌素抑制剂的一种新的结构亚类,有望在治疗方面用于开发急需的新型抗假单胞菌药物。在这种情况下,本研究中使用野生型细胞值得注意,因为所获得的数据与实际情况直接相关。该化合物在更好地阐明绿脓菌素在铜绿假单胞菌感染中的作用方面也可能具有价值。有证据表明,活性化合物通过抑制称为群体感应的细胞间信号传导机制来降低绿脓菌素的产生水平。这可能会产生有趣的影响;群体感应调节一系列与铜绿假单胞菌致病性相关的其他因素,并且在许多其他潜在应用中,抑制群体感应是可取的。